Amir Reza Jalilian

ORCID: 0000-0002-1948-0580

MedicineMaterials Science

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 3 papers. Top paper: “Recent advances and impending challenges for the radiopharmaceutical sciences in oncology”.

Recent advances and impending challenges for the radiopharmaceutical sciences in oncology

The Lancet Oncology(2024)10.1016/s1470-2045(24)00030-5

N/A

0DataRank · unranked

72 citations

Peter J. H. Scott, Andrew M. Scott, Albert D. Windhorst, Brian M. Zeglis, May Abdel–Wahab +14 more

Trends in nuclear medicine and the radiopharmaceutical sciences in oncology: workforce challenges and training in the age of theranostics

The Lancet Oncology(2024)10.1016/s1470-2045(24)00037-8

N/A

0DataRank · unranked

62 citations

Brian M. Zeglis, Suzanne E. Lapi, Peter J. H. Scott, Albert D. Windhorst, May Abdel–Wahab +13 more

Production and regulatory issues for theranostics

The Lancet Oncology(2024)10.1016/s1470-2045(24)00041-x

N/A

0DataRank · unranked

54 citations

Diana Páez, Richard Zimmermann, Cathy S. Cutler, Amir Reza Jalilian, Aruna Korde +12 more